Joel Greenblatt fit · Magic Formula — ROIC alto + EV/EBIT barato
Is Esperion Therapeutics, Inc. (ESPR) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
59/100
CSinais mistos
2/5 critérios atendidos
Os critérios de Joel Greenblatt, aplicados a ESPR
EBIT/EV yield ≥ 10%
chave0.9%
ROIC ≥ 25%
chave26.9%
EV/EBIT ≤ 12
113.4x
Gross margin ≥ 30%
53.5%
Como ESPR pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$626.17M
P/L (TTM)
-
ROIC (TTM)
26.87%
Margem bruta
53.54%
Perguntas frequentes
What is ESPR's Joel Greenblatt fit score?
ESPR scores 59/100 on our Joel Greenblatt fit engine — grade C. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own ESPR?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends ESPR.
How often is this score updated?
ESPR's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Joel Greenblatt possua ou recomende ESPR pessoalmente.